Is the human G147D-protein phosphatase 1 inhibitor-1 polymorphism associated with altered clinical characteristics in heart failure?
The present findings indicate that the human inhibitor-1 G147D polymorphism, found almost exclusively in blacks, may act as a modifier rather than risk factor in heart failure development.
These findings suggest that pirfenidone can attenuate the limited fibrotic potential of tacrolimus.